Cleared Traditional

K242728 - BeneVision Central Monitoring System (FDA 510(k) Clearance)

Jul 2025
Decision
324d
Days
Class 2
Risk

K242728 is an FDA 510(k) clearance for the BeneVision Central Monitoring System. This device is classified as a System, Network And Communication, Physiological Monitors (Class II - Special Controls, product code MSX).

Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on July 31, 2025, 324 days after receiving the submission on September 10, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2300.

Submission Details

510(k) Number K242728 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2024
Decision Date July 31, 2025
Days to Decision 324 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MSX — System, Network And Communication, Physiological Monitors
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2300